“Real World Data Survival Outcomes of First Line Immunotherapy with Pembrolizumab in High Expressers with stage IV Non-Small Cell Lung Cancer” (2026) Radiology and Oncology, 60(3), pp. 450–458. Available at: https://radioloncol.com/index.php/ro/article/view/4876 (Accessed: 22 September 2026).